A full all-around nonclinical project team
Our nonclinical experience in drug development allows the flexibility needed to progress your project
Your nonclinical solution
Our Services
We offer a wide range of services that will bring the nonclinical experience needed to progress your drug products through all regulatory milestones and to market
IND enabling project support and evaluation
We will guide your project to meet the necessary regulatory requirements and evaluate potential for proof of principle
Translational Science
We will help you prepare for first-in-human studies, advise on safe first dose guidance, and develop an effective translational biomarker strategy
Scientific and regulatory writing
We are highly experienced in writing regulatory documentation needed in all stages of development
'We will bring the nonclinical experience needed to progress your drug product through regulatory milestones and to market'
Meet The Team
We are a group of passionate scientists that bring together decades of drug discovery and development experience in pharmacology, toxicology and all types of regulatory interaction and documentation
Peter Gilmour (PhD)
Critical, hands-on expert in drug development pharmacology and toxicology who delivers
Annelieke Peters (PhD ERT)
Enthusiastic expert in toxicology, key focus in pediatric drug development
Anja Slikkerveer (MD PhD ERT)
A pragmatic professional with over 30 years experience in nonclinical drug development
Danny Burg (PhD ERT)
Dependable, results-driven drug discovery and development expert